approved in 2019, Spravato, a depression treatment derived from the club drug ketamine, was looking like a dud. But recently it has taken off, and it surpassed $1 billion in annual sales last year for its maker, Johnson and Johnson.

Further Listening:

-A Lawyer Says He Doesn't Need Help for Psychosis. His Family Disagrees.

-America's Maternal Mental Health Crisis

Further Reading:

-J&J’s Ketamine-Derived Drug Is Taking Off

-Big Pharma Walked Away From Mental Health. Why Some Are Coming Back.

Learn more about your ad choices. Visit megaphone.fm/adchoices

1d:T6c3,Doctors told a teenage Laura Delano she had something they called bipolar disorder, and then proceeded to make her legitimately crazy with psych drugs. She’s one of the few who recovered. (00:00) Introduction (01:20) Why Is the New York Times Mad at Delano for Getting off Antidepressants? (15:32) The Major Problem With Psychiatry Diagnoses (34:43) How Many Americans Are on Psychiatric Drugs? (55:00) The Drugs That Kill Your Life-Force Paid partnerships with: ExpressVPN: Go to https://ExpressVPN.com/Tucker and find out how you can get 4 months of ExpressVPN free! PureTalk: Go to https://PureTalk.com/Tucker to make the switch Policygenius: Head to at https://Policygenius.com/Tucker to see how much you could save Laura Delano is an author, speaker, and consultant, and the founder of Inner Compass Initiative, a nonprofit organization that helps people make

The New Hit Depression Treatment? A Keta...